Algert Global’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$398K Sell
14,239
-26,560
-65% -$747K ﹤0.01% 1103
2026
Q1
$1.16M Sell
40,799
-220,678
-84% -$7.53M 0.02% 836
2025
Q4
$10.3M Buy
261,477
+114,439
+78% +$4.2M 0.16% 182
2025
Q3
$5.18M Buy
147,038
+90,969
+162% +$3.13M 0.09% 404
2025
Q2
$1.84M Hold
56,069
0.04% 658
2025
Q1
$1.81M Sell
56,069
-40,130
-42% -$1.49M 0.04% 627
2024
Q4
$2.94M Buy
96,199
+8,787
+10% +$283K 0.07% 474
2024
Q3
$2.45M Sell
87,412
-3,510
-4% -$86.5K 0.07% 491
2024
Q2
$2.07M Sell
90,922
-9,918
-10% -$229K 0.07% 456
2024
Q1
$3.07M Buy
100,840
+56,100
+125% +$1.88M 0.12% 287
2023
Q4
$1.6M Buy
44,740
+4,570
+11% +$170K 0.06% 484
2023
Q3
$1.76M Buy
40,170
+1,090
+3% +$53.2K 0.08% 407
2023
Q2
$1.93M Buy
+39,080
New +$1.8M 0.08% 396
2023
Q1
Sell
-9,169
Closed -$407K 1135
2022
Q4
$407K Sell
9,169
-30,290
-77% -$1.27M 0.02% 866
2022
Q3
$1.54M Buy
39,459
+33,049
+516% +$1.51M 0.09% 363
2022
Q2
$262K Buy
+6,410
New +$304K 0.02% 949

Other funds holding ATRC

Algert Global's ATRC Position: Q2 2026 in Review

Algert Global reduced its AtriCure (ATRC) stake by 65% in Q2 2026, selling an estimated $747K and leaving 14,239 shares worth $398K. The position accounts for ﹤0.01% of the portfolio, ranked #1103.

Algert Global first reported a position in ATRC in Q2 2022 and has held it in 16 quarters since. The position peaked at $10.3M in Q4 2025. 252 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.

  • Algert Global held 14,239 shares of AtriCure worth $398K as of Q2 2026.
  • Algert Global sold 26,560 AtriCure shares in Q2 2026, an estimated $747K.
  • AtriCure made up ﹤0.01% of Algert Global's portfolio in Q2 2026, its #1103 holding.
  • Algert Global first reported a position in AtriCure in Q2 2022 and has held it in 16 quarters since.
  • Algert Global's AtriCure position peaked at $10.3M in Q4 2025.
  • 252 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.

Based on Algert Global's 13F filing for Q2 2026, filed 13 Aug 2026.